Know Labs’ non-invasive glucose monitor achieves 11.1% MARD in first study
including participants with diabetes and venous blood as a comparative reference.
Results presented at ATTD. See press release HERE.
Bio-RFID uses electromagnetic energy in the form of radio waves to non-invasively capture molecular signatures.
Bio
Body
R
Radio
F
Frequency
Identification
Blood Glucose is Our Priority
Pre-diabetes
~1,500M
Type 2
~450M
Type 1
~50M
Number of people with diabetes in the world
- World Bank, 2020E
We are committed to making a difference in the lives of millions of people around the world.
Our journey begins with a focus on the nearly 500 million people living with Type 1 and Type 2 diabetes, and another 1.5 billion people suffering from pre-diabetes.
Our Solutions to Blood
Glucose Monitoring
Pain-Free
No finger pricks nor continuously inserted transmitters
AI-Powered
Cutting-edge AI powering accurate predictive diagnosis (>95%)
Affordable
No consumables
3x-5x less expensive
than current options
PRODUCTS
KnowU
On-demand and On-the-Go
Place your palm or hold detachable portion for a spot reading of glucose concentration in mg/dL.
UBand
Continuous and Wearable
Put it on your wrist and forget it.
Check your glucose concentration
through your Know Labs app.
"KnowU and UBand will transform how patients manage their diabetes. KnowU is perfect for those looking to replace the painful finger sticks while UBand is an easy-to-use innovation for those that need constant monitoring of their blood glucose."
-Phil Bosua, Bio-RFID Inventor
Know Labs Glucose Monitoring Devices will connect to its smartphone App via Bluetooth and will be available on both the App Store and Google Play
Path to Market
Know Labs is advancing the testing of Bio-RFID, progressing on the path to FDA submission for clerance as a medical-grade device.
Internal Research Validation
Know Labs’ product development and engineering teams conducted hundreds of tests validating the Bio-RFID technology and comparing its accuracy to other FDA cleared glucose monitoring devices.
External Research Validation
Know Labs recently completed in vitro tests with renowned academic medical center to validate that Bio-RFID is able to precisely and non-invasively measure and identify a variety of molecules. In vivo tests to be kicked-off and completed soon.
Development Progress
Our clinical team collects thousands of data points each time a glucose test is performed. The Know Labs' team of data scientists uses this data to refine the algorithm that controls and enables Bio-RFID to identify and measure glucose.
Internal Trial
We compared our benchtop prototype to the FDA-cleared Accu-Chek® and minimally invasive Dexcom®G6 and Freestyle Libre®. Our results are just as accurate or better. This is a big deal.
